Protagenic Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $25 | $0 | $3 | $0 |
Gross Profit | 25 | -12 | -12 | |
EBITDA | -665 | -1,593 | -1,711 | |
EBIT | -678 | -1,606 | -1,724 | |
Net Income | -640 | -1,606 | -1,724 | -1,676 |
Net Change In Cash | 25 | 0 | 3 | 0 |
Free Cash Flow | -185 | -1,551 | -1,659 | -1,238 |
Cash | 1,055 | 924 | 831 | 1,287 |
Basic Shares | 4,529 | 4,443 | 4,435 | 4,435 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | |||
EBITDA | -4,498 | -3,418 | -4,140 | -2,551 |
EBIT | -4,526 | -3,418 | -4,140 | -2,551 |
Net Income | -5,000 | -3,601 | -4,986 | -2,794 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,853 | -1,995 | -2,798 | -1,348 |
Cash | 1,287 | 215 | 541 | 671 |
Basic Shares | 4,344 | 4,317 | 3,685 | 2,584 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.14 |
2024-06-30 | -$0.36 |
2024-03-31 | -$0.38 |
2023-09-30 | -$0.32 |
